[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@QuantumBP Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::1012892543925850113.png) @QuantumBP Quantum BioPharma

Quantum BioPharma posts on X about $qntm, nasdaq, signa, marks the most. They currently have XXXXX followers and XX posts still getting attention that total XXXXX engagements in the last XX hours.

### Engagements: XXXXX [#](/creator/twitter::1012892543925850113/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1012892543925850113/c:line/m:interactions.svg)

- X Week XXXXXX +72%
- X Month XXXXXXX +76%
- X Months XXXXXXX +550%
- X Year XXXXXXX +870%

### Mentions: X [#](/creator/twitter::1012892543925850113/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1012892543925850113/c:line/m:posts_active.svg)

- X Week X -XX%
- X Month XX +53%
- X Months XX +577%
- X Year XX +281%

### Followers: XXXXX [#](/creator/twitter::1012892543925850113/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1012892543925850113/c:line/m:followers.svg)

- X Week XXXXX +0.09%
- X Month XXXXX +1.70%
- X Months XXXXX +6.30%
- X Year XXXXX +5%

### CreatorRank: XXXXXXXXX [#](/creator/twitter::1012892543925850113/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1012892543925850113/c:line/m:influencer_rank.svg)

### Social Influence [#](/creator/twitter::1012892543925850113/influence)
---

**Social category influence**
[exchanges](/list/exchanges)  XX%

**Social topic influence**
[$qntm](/topic/$qntm) 40%, [nasdaq](/topic/nasdaq) 20%, [signa](/topic/signa) 10%, [marks](/topic/marks) XX%

**Top accounts mentioned or mentioned by**
[@bullishlyfree](/creator/undefined) [@smallcapcanada](/creator/undefined) [@agoracom](/creator/undefined) [@useless_cog](/creator/undefined) [@goldgokutrader](/creator/undefined) [@angelicsurvivor](/creator/undefined) [@linhnguyen64143](/creator/undefined) [@6days1week](/creator/undefined) [@msnewstoday](/creator/undefined) [@justinbrewer33](/creator/undefined) [@malone_wealth](/creator/undefined) [@matthewwal57743](/creator/undefined) [@game_lnformer](/creator/undefined) [@advisorshares](/creator/undefined) [@platnumsparkles](/creator/undefined) [@nipomo357](/creator/undefined) [@crispytots4u](/creator/undefined) [@gheyteeay](/creator/undefined) [@djdarroo](/creator/undefined)
### Top Social Posts [#](/creator/twitter::1012892543925850113/posts)
---
Top posts by engagements in the last XX hours

"NEWS RECAP JUNE 17th 2025 Quantum BioPharma ($QNTM) and Massachusetts General Hospital (MGH) have officially scanned the first person with Multiple Sclerosis using a next-generation PET-MR imaging tracerF3F4AP Using latest tech GE Signa PET-MR. This groundbreaking joint study is designed to evaluate a novel PET biomarker that detects myelin damage in the brain and spinal cord with unprecedented clarity. The goal To transform how MS drug candidates are measured for remyelination and neuroprotectionushering in a new era of precision imaging in MS research. 🧠 Precision PET imaging 🤝 Leading"  
![@QuantumBP Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1012892543925850113.png) [@QuantumBP](/creator/x/QuantumBP) on [X](/post/tweet/1942255186853933059) 2025-07-07 16:11:36 UTC 5749 followers, 13.6K engagements


"🔬 Advancing the Science of Demyelination. Dedicated to Addressing the Complexities of Neurodegenerative Disease. Quantum BioPharma Operates with Scientific Integrity at Every Step. Learn more at: 🌐 #Biotech #MultipleSclerosis #Demyelination $QNTM #Pharma #Neurodegeneration #Microcap #ClinicalTrials"  
![@QuantumBP Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1012892543925850113.png) [@QuantumBP](/creator/x/QuantumBP) on [X](/post/tweet/1943664683593916832) 2025-07-11 13:32:26 UTC 5745 followers, 2938 engagements


"Quantum BioPharma has submitted its patented MS drug candidate Lucid-21-302 (Lucid-MS) to the UKs Innovative Licensing and Access Pathway (ILAP) fast-track program. Lucid-MS is a first-in-class treatment targeting demyelination in Multiple Sclerosis. The ILAP submission marks a key step in accelerating regulatory review clinical development and patient access in the UK. #QNTM #LucidMS #Biotech #Neurodegeneration #MultipleSclerosis #DrugDevelopment #ClinicalTrials #UKLifeSciences #ILAP #MSawareness #NASDAQ $QNTM #Brainhealth #News #NHS"  
![@QuantumBP Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1012892543925850113.png) [@QuantumBP](/creator/x/QuantumBP) on [X](/post/tweet/1942555207658795215) 2025-07-08 12:03:47 UTC 5745 followers, 17.7K engagements


"3rd Party Article @MSNewsToday #Multiplesclerosis #MS #Biotech #Nasdaq $QNTM #Neurodegenerative"  
![@QuantumBP Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1012892543925850113.png) [@QuantumBP](/creator/x/QuantumBP) on [X](/post/tweet/1944751782069973090) 2025-07-14 13:32:11 UTC 5749 followers, 55.5K engagements